TMX Newsfile

IN THE PRESS

Press Releases

BioMark Diagnostics Announces Publication of Peer-Reviewed Validation of Machine Learning Models for Lung Cancer Detection in Frontiers in Oncology

January 15, 2026

·

4 min read

Press Releases

Phio Pharmaceuticals Announces Participation in the Sidoti Micro-Cap Virtual Investor Conference January 21-22, 2026

January 15, 2026

·

5 min read

Press Releases

PharmaTher Expands PharmaPatch(TM) Platform into GLP-1 for Obesity, Leveraging Its Ketamine and Psychedelic Patch Programs

January 14, 2026

·

6 min read

Press Releases

OS Therapies Announces Filing Form S-1 of OS Animal Health Subsidiary

January 14, 2026

·

8 min read

Press Releases

TempraMed Receives Positive Response on Payor Reimbursement Model Driving Significant Return on Investment for Medical Payor Coverage

January 14, 2026

·

7 min read

Press Releases

Cardiol Therapeutics Achieves Key 50% Patient Enrollment Milestone in Pivotal Phase III MAVERIC Trial in Recurrent Pericarditis

January 13, 2026

·

7 min read

Press Releases

TempraMed Closes C$2.5 Million Fully Subscribed Private Placement

January 13, 2026

·

6 min read

Press Releases

OS Therapies Enters into Warrant Inducement Agreements

January 12, 2026

·

7 min read

Press Releases

DaCapo Brainscience Appoints Leslie Williams as President & Chief Executive Officer; Announces Mridul Mehta, PhD, as Chief Technology Officer and Promotes Warren Hirst, PhD, to Chief Scientific Officer

January 12, 2026

·

1 min read

Press Releases

Ferring Pharmaceuticals and Theralase(R) Technologies Announce Clinical Development Agreement to Investigate Combination Therapy in Bladder Cancer

January 12, 2026

·

13 min read

15 Toronto St., Suite 601 Toronto ON M5C 2E3 US

Tel: 416-806-1750